Refer
Print
ins免费加速器ios
Oligomerix® Vision
To discover novel and differentiated small molecules and biomarkers focused on tau oligomer inhibition for the disease-modifying treatment of Alzheimer’s disease and other related neurodegenerative diseases
ins免费加速器ios
ins免费加速器ios
ins免费加速器ios
ins免费加速器ios
Click here to read the full publication
Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data
Click here to read the full news story